InMode Ltd. (INMD)

Market Cap	1.54B
Revenue (ttm)	423.75M
Net Income (ttm)	153.67M
Shares Out	84.62M
EPS (ttm)	1.84
PE Ratio	9.93
Forward PE	8.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,438,696
Open	17.53
Previous Close	17.71
Day's Range	17.46 - 18.30
52-Week Range	14.87 - 26.80
Beta	2.15
Analysts	Buy
Price Target	22.60 (+23.9%)
Earnings Date	Oct 30, 2024

About INMD

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. It also des...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2019
• Employees: 581
• Stock Exchange: NASDAQ
• Ticker Symbol: INMD
• Website: https://www.inmodemd.com

Financial Performance

In 2023, InMode's revenue was $492.05 million, an increase of 8.32% compared to the previous year's $454.27 million. Earnings were $197.92 million, an increase of 22.54%.

Analyst Forecast

According to 6 analysts, the average rating for INMD stock is "Buy." The 12-month stock price forecast is $22.6, which is an increase of 23.90% from the latest price.

Price Target

$22.6

(23.90% upside)

Analyst Consensus: Buy